Paclitaxel Plus Pazopanib for Persistent or Recurrent Ovarian Cancer

This phase 2 randomized clinical trial evaluates the effects of pazopanib in combination with paclitaxel vs paclitaxel and placebo on survival in patients with recurrent ovarian cancer.

http://ift.tt/2jU0Q28